Synergy and oxygen adaptation for development of next-generation probiotics.
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
30
06
2021
accepted:
27
06
2023
medline:
11
8
2023
pubmed:
3
8
2023
entrez:
2
8
2023
Statut:
ppublish
Résumé
The human gut microbiota has gained interest as an environmental factor that may contribute to health or disease
Identifiants
pubmed: 37532933
doi: 10.1038/s41586-023-06378-w
pii: 10.1038/s41586-023-06378-w
pmc: PMC10412450
doi:
Substances chimiques
Butyrates
0
Oxygen
S88TT14065
Banques de données
ClinicalTrials.gov
['NCT03728868']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
381-385Informations de copyright
© 2023. The Author(s).
Références
Schroeder, B. O. & Backhed, F. Signals from the gut microbiota to distant organs in physiology and disease. Nat. Med. 22, 1079–1089 (2016).
pubmed: 27711063
doi: 10.1038/nm.4185
O’Toole, P. W., Marchesi, J. R. & Hill, C. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat. Microbiol. 2, 17057 (2017).
pubmed: 28440276
doi: 10.1038/nmicrobiol.2017.57
Sender, R., Fuchs, S. & Milo, R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14, e1002533 (2016).
pubmed: 27541692
pmcid: 4991899
doi: 10.1371/journal.pbio.1002533
Li, J. et al. An integrated catalog of reference genes in the human gut microbiome. Nat. Biotechnol. 32, 834–841 (2014).
pubmed: 24997786
doi: 10.1038/nbt.2942
Allin, K. H. et al. Aberrant intestinal microbiota in individuals with prediabetes. Diabetologia 61, 810–820 (2018).
pubmed: 29379988
pmcid: 6448993
doi: 10.1007/s00125-018-4550-1
Wu, H. et al. The gut microbiota in prediabetes and diabetes: a population-based cross-sectional study. Cell Metab. 32, 379–390.e3 (2020).
pubmed: 32652044
doi: 10.1016/j.cmet.2020.06.011
Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55–60 (2012).
pubmed: 23023125
doi: 10.1038/nature11450
Fu, J. Y. et al. The gut microbiome contributes to a substantial proportion of the variation in blood lipids. Circ. Res. 117, 817–824 (2015).
pubmed: 26358192
pmcid: 4596485
doi: 10.1161/CIRCRESAHA.115.306807
Sokol, H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl Acad. Sci. USA 105, 16731–16736 (2008).
pubmed: 18936492
pmcid: 2575488
doi: 10.1073/pnas.0804812105
Cao, Y., Shen, J. & Ran, Z. H. Association between Faecalibacterium prausnitzii reduction and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Gastroent. Res. Pract. 2014, 872725 (2014).
doi: 10.1155/2014/872725
De Filippis, F., Pasolli, E. & Ercolini, D. Newly explored Faecalibacterium diversity is connected to age, lifestyle, geography, and disease. Curr. Biol. 30, 4932–4943 (2020).
pubmed: 33065016
doi: 10.1016/j.cub.2020.09.063
Koh, A., De Vadder, F., Kovatcheva-Datchary, P. & Backhed, F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165, 1332–1345 (2016).
pubmed: 27259147
doi: 10.1016/j.cell.2016.05.041
Wang, S. P. et al. Pivotal roles for pH, lactate, and lactate-utilizing bacteria in the stability of a human colonic microbial ecosystem. mSystems 5, e00645-20 (2020).
pubmed: 32900872
pmcid: 7483512
doi: 10.1128/mSystems.00645-20
Smith, N. W., Shorten, P. R., Altermann, E. H., Roy, N. C. & McNabb, W. C. Hydrogen cross-feeders of the human gastrointestinal tract. Gut Microbes 10, 270–288 (2019).
pubmed: 30563420
doi: 10.1080/19490976.2018.1546522
Warren, Y. A., Citron, D. M., Merriam, C. V. & Goldstein, E. J. C. Biochemical differentiation and comparison of Desulfovibrio species and other phenotypically similar genera. J. Clin. Microbiol. 43, 4041–4045 (2005).
pubmed: 16081948
pmcid: 1233901
doi: 10.1128/JCM.43.8.4041-4045.2005
Olsson, L. M. et al. Dynamics of the normal gut microbiota: a longitudinal one-year population study in Sweden. Cell Host Microbe 30, 726–739.e3 (2022).
Rey, F. E. et al. Metabolic niche of a prominent sulfate-reducing human gut bacterium. Proc. Natl Acad. Sci. USA 110, 13582–13587 (2013).
pubmed: 23898195
pmcid: 3746858
doi: 10.1073/pnas.1312524110
Lopez-Siles, M., Duncan, S. H., Garcia-Gil, L. J. & Martinez-Medina, M. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J. 11, 841–852 (2017).
Khan, M. T. et al. The gut anaerobe Faecalibacterium prausnitzii uses an extracellular electron shuttle to grow at oxic–anoxic interphases. ISME J. 6, 1578–1585 (2012).
Duncan, S. H. et al. Contribution of acetate to butyrate formation by human faecal bacteria. Br. J. Nutr. 91, 915–923 (2004).
pubmed: 15182395
doi: 10.1079/BJN20041150
Duncan, S. H., Hold, G. L., Harmsen, H. J. M., Stewart, C. S. & Flint, H. J. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int. J. Syst. Evol. Microbiol. 52, 2141–2146 (2002).
pubmed: 12508881
Khan, M. T., van Dijl, J. M. & Harmsen, H. J. Antioxidants keep the potentially probiotic but highly oxygen-sensitive human gut bacterium Faecalibacterium prausnitzii alive at ambient air. PLoS ONE 9, e96097 (2014).
pubmed: 24798051
pmcid: 4010535
doi: 10.1371/journal.pone.0096097
Koh, A. et al. Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell 175, 947–961.e17 (2018).
Chen, Y. R. et al. Desulfovibrio is not always associated with adverse health effects in the Guangdong Gut Microbiome Project. PeerJ 9, e12033 (2021).
Gilijamse, P. W. et al. Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose-response effects on glucose metabolism in human subjects with metabolic syndrome. NPJ Biofilms Microbiomes 6, 16 (2020).
pubmed: 32221294
pmcid: 7101376
doi: 10.1038/s41522-020-0127-0
Jie, Z. et al. The baseline gut microbiota directs dieting-induced weight loss trajectories. Gastroenterology 160, 2029–2042.e16 (2021).
pubmed: 33482223
doi: 10.1053/j.gastro.2021.01.029
Rodriguez, J. et al. Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients. Gut 69, 1975–1987 (2020).
pubmed: 32041744
doi: 10.1136/gutjnl-2019-319726
Kootte, R. S. et al. Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition. Cell Metab. 26, 611–619.e616 (2017).
pubmed: 28978426
doi: 10.1016/j.cmet.2017.09.008
Aggarwala, V. et al. Precise quantification of bacterial strains after fecal microbiota transplantation delineates long-term engraftment and explains outcomes. Nat. Microbiol. 6, 1309–1318 (2021).
pubmed: 34580445
pmcid: 8993687
doi: 10.1038/s41564-021-00966-0
Almeida, A. et al. A unified catalog of 204,938 reference genomes from the human gut microbiome. Nat. Biotechnol. 39, 105–114 (2021).
pubmed: 32690973
doi: 10.1038/s41587-020-0603-3
Depommier, C. et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat. Med. 25, 1096–1103 (2019).
pubmed: 31263284
pmcid: 6699990
doi: 10.1038/s41591-019-0495-2
Perraudeau, F. et al. Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation. BMJ Op. Diabetes Res. Care 8, e001319 (2020).
doi: 10.1136/bmjdrc-2020-001319
Morvan, C., Folgosa, F., Kint, N., Teixeira, M. & Martin-Verstraete, I. Responses of Clostridia to oxygen: from detoxification to adaptive strategies. Environ. Microbiol. 23, 4112–4125 (2021).
pubmed: 34245087
doi: 10.1111/1462-2920.15665
Meehan, B. M., Baughn, A. D., Gallegos, R. & Malamy, M. H. Inactivation of a single gene enables microaerobic growth of the obligate anaerobe Bacteroides fragilis. Proc. Natl Acad. Sci. USA 109, 12153–12158 (2012).
pubmed: 22778399
pmcid: 3409759
doi: 10.1073/pnas.1203796109
Loomba, R. et al. Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease. Cell Metab. 25, 1054–1062.e5 (2017).
Khan, M. T., Browne, W. R., van Dijl, J. M. & Harmsen, H. J. How can Faecalibacterium prausnitzii employ riboflavin for extracellular electron transfer? Antioxid. Redox Signal. 17, 1433–1440 (2012).
pubmed: 22607129
doi: 10.1089/ars.2012.4701
Caesar, R., Tremaroli, V., Kovatcheva-Datchary, P., Cani, P. D. & Backhed, F. Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metab. 22, 658–668 (2015).
pubmed: 26321659
pmcid: 4598654
doi: 10.1016/j.cmet.2015.07.026
Wang, R. F., Cao, W. W. & Cerniglia, C. E. PCR detection and quantitation of predominant anaerobic bacteria in human and animal fecal samples. Appl. Environ. Microbiol. 62, 1242–1247 (1996).
pubmed: 8919784
pmcid: 167889
doi: 10.1128/aem.62.4.1242-1247.1996
Suau, A. et al. Fusobacterium prausnitzii and related species represent a dominant group within the human fecal flora. Syst. Appl. Microbiol. 24, 139–145 (2001).
pubmed: 11403393
doi: 10.1078/0723-2020-00015
Fite, A. et al. Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction. Gut 53, 523–529 (2004).
pubmed: 15016746
pmcid: 1774019
doi: 10.1136/gut.2003.031245
Svedlund, J., Sjodin, I. & Dotevall, G. GSRS—a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig. Dis. Sci. 33, 129–134 (1988).
pubmed: 3123181
doi: 10.1007/BF01535722
Bjork, J. et al. Prediction of relative glomerular filtration rate in adults: new improved equations based on Swedish Caucasians and standardized plasma-creatinine assays. Scand. J. Clin. Lab. Invest. 67, 678–695 (2007).
pubmed: 17852799
doi: 10.1080/00365510701326891
Djekic, D. et al. Effects of a vegetarian diet on cardiometabolic risk factors, gut microbiota, and plasma metabolome in subjects with ischemic heart disease: a randomized, crossover study. J. Am. Heart Assoc. 9, e016518 (2020).
pubmed: 32893710
pmcid: 7726986
doi: 10.1161/JAHA.120.016518
Fagerland, M. W., Lydersen, S. & Laake, P. Recommended confidence intervals for two independent binomial proportions. Stat. Methods Med. Res. 24, 224–254 (2015).
pubmed: 21996567
doi: 10.1177/0962280211415469
Bradley, J. V. Distribution-Free Statistical Tests 78–80 (Prentice–Hall, 1968).
Good, P. Permutation Tests: a Practical Guide to Resampling Methods for Testing Hypotheses 36–37 (Springer, 2000).
Strocchi, A., Furne, J. K. & Levitt, M. D. A modification of the methylene-blue method to measure bacterial sulfide production in feces. J. Microbiol. Methods 15, 75–82 (1992).
doi: 10.1016/0167-7012(92)90071-B
Costea, P. I. et al. Towards standards for human fecal sample processing in metagenomic studies. Nat. Biotechnol. 35, 1069–1076 (2017).
pubmed: 28967887
doi: 10.1038/nbt.3960
Marmur, J. A procedure for the isolation of deoxyribonucleic acid from micro-organisms. J. Mol. Biol. 3, 208–218 (1961).
doi: 10.1016/S0022-2836(61)80047-8
Darling, A. E., Mau, B. & Perna, N. T. progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS ONE 5, e11147 (2010).
pubmed: 20593022
pmcid: 2892488
doi: 10.1371/journal.pone.0011147
Kumar, S., Stecher, G., Li, M., Knyaz, C. & Tamura, K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol. Biol. Evol. 35, 1547–1549 (2018).
pubmed: 29722887
pmcid: 5967553
doi: 10.1093/molbev/msy096
Tamura, K., Nei, M. & Kumar, S. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc. Natl Acad. Sci. USA 101, 11030–11035 (2004).
pubmed: 15258291
pmcid: 491989
doi: 10.1073/pnas.0404206101
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
pubmed: 22388286
pmcid: 3322381
doi: 10.1038/nmeth.1923
Wood, D. E., Lu, J. & Langmead, B. Improved metagenomic analysis with Kraken 2. Genome Biol. 20, 257 (2019).
pubmed: 31779668
pmcid: 6883579
doi: 10.1186/s13059-019-1891-0
Lu, J., Breitwieser, F. P., Thielen, P. & Salzbergt, S. L. Bracken: estimating species abundance in metagenomics data. PeerJ Comput. Sci. 3, e104 (2017).
doi: 10.7717/peerj-cs.104
Karlsson, F. H., Nookaew, I. & Nielsen, J. Metagenomic data utilization and analysis (MEDUSA) and construction of a global gut microbial gene catalogue. PLoS Comput. Biol. 10, e1003706 (2014).
pubmed: 25010449
pmcid: 4091689
doi: 10.1371/journal.pcbi.1003706
Vital, M., Howe, A. C. & Tiedje, J. M. Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. mBio 5, e00889 (2014).
pubmed: 24757212
pmcid: 3994512
doi: 10.1128/mBio.00889-14